Covid-19 Impact on Wilson`s Disease Treatment Market, Global Research Reports 2020-2021

June 2020 | 96 pages | ID: C9DE5D895D2AEN
QYResearch

Abstracts

This report covers market size and forecasts of Wilson`s Disease Treatment, including the following market information:

• Global Wilson`s Disease Treatment Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
• Global Wilson`s Disease Treatment Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
• Global Wilson`s Disease Treatment Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
• Global Wilson`s Disease Treatment Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

Key market players

Major competitors identified in this market include Bausch Health, Tsumura & Co, Merck & Co, VHB Life Science Inc., Teva Pharmaceuticals USA, Inc, Wilson’s Therapeutics AB, Noble Pharma Co., Ltd, Kadmon Holding, Inc, etc.

Based on the Region:

• Asia-Pacific (China, Japan, South Korea, India and ASEAN)
• North America (US and Canada)
• Europe (Germany, France, UK and Italy)
• Rest of World (Latin America, Middle East & Africa)

Based on the Type:

• Medications
• Others

Based on the Application:

• Government
• Hospitals
• Medical Practitioners

Contents

1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
  1.4.1 Research Process
  1.4.2 Data Triangulation
  1.4.3 Research Approach
  1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
  1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
  1.5.2 Covid-19 Impact: Commodity Prices Indices
  1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Wilson`s Disease Treatment Industry
1.7 COVID-19 Impact: Wilson`s Disease Treatment Market Trends

2 GLOBAL WILSON`S DISEASE TREATMENT QUARTERLY MARKET SIZE ANALYSIS

2.1 Wilson`s Disease Treatment Business Impact Assessment - COVID-19
  2.1.1 Global Wilson`s Disease Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Wilson`s Disease Treatment Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  2.3.1 Drivers
  2.3.2 Restraints
  2.3.3 Opportunities
  2.3.4 Challenges

3 QUARTERLY COMPETITIVE ASSESSMENT, 2020

3.1 By Players, Global Wilson`s Disease Treatment Quarterly Market Size, 2019 VS 2020
3.2 By Players, Wilson`s Disease Treatment Headquarters and Area Served
3.3 Date of Key Players Enter into Wilson`s Disease Treatment Market
3.4 Key Players Wilson`s Disease Treatment Product Offered
3.5 Mergers & Acquisitions, Expansion Plans

4 IMPACT OF COVID-19 ON WILSON`S DISEASE TREATMENT SEGMENTS, BY TYPE

4.1 Introduction
  1.4.1 Medications
  1.4.2 Others
4.2 By Type, Global Wilson`s Disease Treatment Market Size, 2019-2021

5 IMPACT OF COVID-19 ON WILSON`S DISEASE TREATMENT SEGMENTS, BY APPLICATION

5.1 Overview
  5.5.1 Government
  5.5.2 Hospitals
  5.5.3 Medical Practitioners
5.2 By Application, Global Wilson`s Disease Treatment Market Size, 2019-2021
  5.2.1 By Application, Global Wilson`s Disease Treatment Market Size by Application, 2019-2021

6 GEOGRAPHIC ANALYSIS

6.1 Introduction
6.2 North America
  6.2.1 Macroeconomic Indicators of US
  6.2.2 US
  6.2.3 Canada
6.3 Europe
  6.3.1 Macroeconomic Indicators of Europe
  6.3.2 Germany
  6.3.3 France
  6.3.4 UK
  6.3.5 Italy
6.4 Asia-Pacific
  6.4.1 Macroeconomic Indicators of Asia-Pacific
  6.4.2 China
  6.4.3 Japan
  6.4.4 South Korea
  6.4.5 India
  6.4.6 ASEAN
6.5 Rest of World
  6.5.1 Latin America
  6.5.2 Middle East and Africa

7 COMPANY PROFILES

7.1 Bausch Health
  7.1.1 Bausch Health Business Overview
  7.1.2 Bausch Health Wilson`s Disease Treatment Quarterly Revenue, 2020
  7.1.3 Bausch Health Wilson`s Disease Treatment Product Introduction
  7.1.4 Bausch Health Response to COVID-19 and Related Developments
7.2 Tsumura & Co
  7.2.1 Tsumura & Co Business Overview
  7.2.2 Tsumura & Co Wilson`s Disease Treatment Quarterly Revenue, 2020
  7.2.3 Tsumura & Co Wilson`s Disease Treatment Product Introduction
  7.2.4 Tsumura & Co Response to COVID-19 and Related Developments
7.3 Merck & Co
  7.3.1 Merck & Co Business Overview
  7.3.2 Merck & Co Wilson`s Disease Treatment Quarterly Revenue, 2020
  7.3.3 Merck & Co Wilson`s Disease Treatment Product Introduction
  7.3.4 Merck & Co Response to COVID-19 and Related Developments
7.4 VHB Life Science Inc.
  7.4.1 VHB Life Science Inc. Business Overview
  7.4.2 VHB Life Science Inc. Wilson`s Disease Treatment Quarterly Revenue, 2020
  7.4.3 VHB Life Science Inc. Wilson`s Disease Treatment Product Introduction
  7.4.4 VHB Life Science Inc. Response to COVID-19 and Related Developments
7.5 Teva Pharmaceuticals USA, Inc
  7.5.1 Teva Pharmaceuticals USA, Inc Business Overview
  7.5.2 Teva Pharmaceuticals USA, Inc Wilson`s Disease Treatment Quarterly Revenue, 2020
  7.5.3 Teva Pharmaceuticals USA, Inc Wilson`s Disease Treatment Product Introduction
  7.5.4 Teva Pharmaceuticals USA, Inc Response to COVID-19 and Related Developments
7.6 Wilson’s Therapeutics AB
  7.6.1 Wilson’s Therapeutics AB Business Overview
  7.6.2 Wilson’s Therapeutics AB Wilson`s Disease Treatment Quarterly Revenue, 2020
  7.6.3 Wilson’s Therapeutics AB Wilson`s Disease Treatment Product Introduction
  7.6.4 Wilson’s Therapeutics AB Response to COVID-19 and Related Developments
7.7 Noble Pharma Co., Ltd
  7.7.1 Noble Pharma Co., Ltd Business Overview
  7.7.2 Noble Pharma Co., Ltd Wilson`s Disease Treatment Quarterly Revenue, 2020
  7.7.3 Noble Pharma Co., Ltd Wilson`s Disease Treatment Product Introduction
  7.7.4 Noble Pharma Co., Ltd Response to COVID-19 and Related Developments
7.8 Kadmon Holding, Inc
  7.8.1 Kadmon Holding, Inc Business Overview
  7.8.2 Kadmon Holding, Inc Wilson`s Disease Treatment Quarterly Revenue, 2020
  7.8.3 Kadmon Holding, Inc Wilson`s Disease Treatment Product Introduction
  7.8.4 Kadmon Holding, Inc Response to COVID-19 and Related Developments

8 KEY FINDINGS

9 APPENDIX

9.1 About US
9.2 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Wilson`s Disease Treatment Assessment
Table 9. COVID-19 Impact: Wilson`s Disease Treatment Market Trends
Table 10. COVID-19 Impact Global Wilson`s Disease Treatment Market Size
Table 11. Global Wilson`s Disease Treatment Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Wilson`s Disease Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Wilson`s Disease Treatment Market Growth Drivers
Table 14. Global Wilson`s Disease Treatment Market Restraints
Table 15. Global Wilson`s Disease Treatment Market Opportunities
Table 16. Global Wilson`s Disease Treatment Market Challenges
Table 17. By Players, Wilson`s Disease Treatment Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Wilson`s Disease Treatment Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Wilson`s Disease Treatment Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Wilson`s Disease Treatment Market
Table 21. Key Players Wilson`s Disease Treatment Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Wilson`s Disease Treatment Market Size 2019-2021, (US$ Million)
Table 24. Global Wilson`s Disease Treatment Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Wilson`s Disease Treatment Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Wilson`s Disease Treatment Market Size, 2019-2021 (US$ Million)
Table 57. Bausch Health Business Overview
Table 58. Bausch Health Wilson`s Disease Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Bausch Health Wilson`s Disease Treatment Product
Table 60. Bausch Health Response to COVID-19 and Related Developments
Table 61. Tsumura & Co Business Overview
Table 62. Tsumura & Co Wilson`s Disease Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Tsumura & Co Wilson`s Disease Treatment Product
Table 64. Tsumura & Co Response to COVID-19 and Related Developments
Table 65. Merck & Co Business Overview
Table 66. Merck & Co Wilson`s Disease Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Merck & Co Wilson`s Disease Treatment Product
Table 68. Merck & Co Response to COVID-19 and Related Developments
Table 69. VHB Life Science Inc. Business Overview
Table 70. VHB Life Science Inc. Wilson`s Disease Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. VHB Life Science Inc. Wilson`s Disease Treatment Product
Table 72. VHB Life Science Inc. Response to COVID-19 and Related Developments
Table 73. Teva Pharmaceuticals USA, Inc Business Overview
Table 74. Teva Pharmaceuticals USA, Inc Wilson`s Disease Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Teva Pharmaceuticals USA, Inc Wilson`s Disease Treatment Product
Table 76. Teva Pharmaceuticals USA, Inc Response to COVID-19 and Related Developments
Table 77. Wilson’s Therapeutics AB Business Overview
Table 78. Wilson’s Therapeutics AB Wilson`s Disease Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Wilson’s Therapeutics AB Wilson`s Disease Treatment Product
Table 80. Wilson’s Therapeutics AB Response to COVID-19 and Related Developments
Table 81. Noble Pharma Co., Ltd Business Overview
Table 82. Noble Pharma Co., Ltd Wilson`s Disease Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Noble Pharma Co., Ltd Wilson`s Disease Treatment Product
Table 84. Noble Pharma Co., Ltd Response to COVID-19 and Related Developments
Table 85. Kadmon Holding, Inc Business Overview
Table 86. Kadmon Holding, Inc Wilson`s Disease Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Kadmon Holding, Inc Wilson`s Disease Treatment Product
Table 88. Kadmon Holding, Inc Response to COVID-19 and Related Developments

List Of Figures

LIST OF FIGURES

Figure 1. Wilson`s Disease Treatment Product Picture
Figure 2. Wilson`s Disease Treatment Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Wilson`s Disease Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Wilson`s Disease Treatment Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Wilson`s Disease Treatment Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Wilson`s Disease Treatment Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Wilson`s Disease Treatment Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Wilson`s Disease Treatment Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Wilson`s Disease Treatment Market Size Market Share, 2019-2021